FDA Inspection 1092259 — Amit (nmi)Mahipal MD
The FDA completed an inspection of Amit (nmi)Mahipal MD on May 21, 2019 in Rochester, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 21, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Rochester, MN (United States)
Additional Details
Clinical Investigator (CI)